K014121 · Nellcor Puritan Bennett, Inc. · DWJ · Jan 11, 2002 · Cardiovascular
Device Facts
Record ID
K014121
Device Name
WARMTOUCH CARDIAC BLANKET,CATALOG # 503-0860
Applicant
Nellcor Puritan Bennett, Inc.
Product Code
DWJ · Cardiovascular
Decision Date
Jan 11, 2002
Decision
SESE
Submission Type
Special
Regulation
21 CFR 870.5900
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The WarmTouch Patient Warming System (warming unit and blanket) is intended for prevention and treatment of hypothermia and/or shivering in the critical care environment.
Device Story
WarmTouch CareDrape Cardiac Blanket is a convective air warming blanket used in operating rooms to manage patient body temperature. It functions by distributing warm air from a warming unit through the blanket to the patient. The device features slits for patient access and is sterile, allowing use within the sterile field. It is operated by healthcare professionals in clinical settings. The blanket helps prevent or treat hypothermia and shivering, potentially improving patient outcomes during surgical procedures.
Clinical Evidence
Bench testing only. Testing verified a maximum temperature of 40.5°C at the nozzle and a temperature difference of <5°C across the blanket surface. Robustness testing included burst pressure and tape strength measurements conducted pre- and post-sterilization and accelerated aging to simulate shelf life. No clinical data was provided.
Technological Characteristics
Convective air warming blanket. Materials include adhesive tape and flexible blanket material. Designed for use with a forced-air warming unit. Features include access slits and sterile packaging. Performance specifications follow draft ASTM standard for Circulating Liquid and Forced Air Patient Temperature Management Devices. Maximum temperature output 40.5°C; temperature uniformity <5°C across surface.
Indications for Use
Indicated for prevention and treatment of hypothermia and/or shivering in patients in the critical care environment.
Regulatory Classification
Identification
A thermal regulating system is an external system consisting of a device that is placed in contact with the patient and a temperature controller for the device. The system is used to regulate patient temperature.
Predicate Devices
CareDrape™ Lower Body Blanket (Cat #503-0830)
CareQuilt™ Full Body/ Multi-Access Warming Blanket (Cat #503-0810)
Related Devices
K040632 — SNUGGLE WARM 4000 CONVECTIVE WARMING SYSTEM, MODEL SW4000 · Smiths Medical Asd, Inc. · Apr 27, 2004
K060200 — MICROTEK MEDICAL WARMING DRAPE · Microtek Medical, Inc. · May 31, 2006
K964673 — BAIR HUGGER MODEL 630 CARDIAC BLANKET · Augustine Medical, Inc. · Jun 26, 1997
K960511 — GIBECK WARMBAG REUSABLE CONVECTIVE WARMING BLANKET · Gibeck, Inc. · Jan 13, 1997
Submission Summary (Full Text)
{0}------------------------------------------------
## JAN 1 1 2002
K014121
# 510(k) Summary of Safety and Effectiveness
This 510(k) Summary of Safety and Effectiveness is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
Submitter's Name: Nellcor Puritan Bennett, Inc.
Submitter's Address: 4280 Hacienda Drive Pleasanton, CA 94588-8604
Contact Person: Anthony Mullin Phone Number: 314-654-3049 FAX Number: 314-654-3344 Summary Date: December 5, 2001
Device Trade Name: WarmTouch® CareQuilt™ Cardiac Blanket
Common Name: Convective Air Warming Blanket
- Device Classification Names: The FDA has classified Thermal Regulation Systems as Class II devices under CFR Title 21, Section 870-5900. The product code is DWJ
- Predicate Devices: CareDrape™ Lower Body Blanket, Cat #503-0830 CareQuilt™ Full Body/ Multi-Access Warming Blanket, Cat #503-0810.
Device Description: The Warm Touch® CareDrape™ Cardiac Blanket is similar to the CareDrape™ Lower Body Blanket in use, as both are used in the operating room to help manage the patient's body temperature. The WarmTouch® CareDrape™ Cardiac Blanket is similar to the CareQuilt™ Full Body/ Multi-Access Warming Blanket, as both are equipped with slits, which can be opened for access to the patient through the blanket. The kev difference between the Cardiac Blanket and all earlier WarmTouch® blankets is that the Cardiac Blanket is sterile permitting use of the blanket within the sterile field.
- Indications For Use: The WarmTouch Patient Warming System (warming unit and blanket) is intended for prevention and treatment of hypothermia and/or shivering in the critical care environment.
Contraindications: There are no contraindications for the use of this device
### Summary of Performance Testing:
#### Maximum Temperature delivered to the patient �
The blankets were tested according to the draft ASTM standard Standard Specification for Circulating Liquid and Forced Air Patient Temperature Management Devices. This testing vertfied that the blanket maintained a maximum temperature of 40.5℃. This maximum temperature is located immediately in front of the nozzle tube.
{1}------------------------------------------------
#### Temperature range .
i emperature range The blankels were tosted docoraing to the nemerature Management Devices. This testing Cilculaung Liquid and I olecu Air Patche Formprature difference of <5°C across its area.
#### Burst Pressure -- Pre/post sterilization and aging .
Burst Pressure of the blankets was tested in the same way as the currently marketed The Durst 1 the blankets are inflated until they burst, and the burst pressure wan i r ouch blankets . The blankets met the same robustness requirements as do the predicate blankets.
#### Tape strength – pre/post sterilization and aging .
Tape Strength of the tape bond was measured before and after accelerated aging (2 The tentile strength of the tape Dond was mousures . These levels bracket the typical year equivalent) and aller of levels of Rudition expective effects on the tape adhesive.
#### Conclusions:
The WarmTouch® CareDrape™ Cardiac Blanket performs as intended according to its The Wallin Ouch® CareDrape - Garaldo Liamist persone™ Cardiac Blanket is substantially equivalent to the predicate devices.
{2}------------------------------------------------
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 11 2002
Mr. Anthony M. Mullin Assistant Director, Regulatory and Clinical Affairs Nellcor Puritan Bennett, Inc. 4280 Hacienda Drive Pleasanton, CA 94588
Re: K014121
Trade Name: WarmTouch® CareDrape™ Cardiac Blanket Regulation Number: 21 CFR 870.5900 Regulation Name: Convective Air Warming Blanket Regulatory Class: Class II (two) Product Code: DWJ Dated: December 6, 2001 Received: December 17, 2001
## Dear Mr. Mullin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Mr. Anthony M. Mullin
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
A. Dattell
Bram D. Zuckerman, M.D. Acting Director Division of Cardiovascular And Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
510(k) Number (if known):
K014121
Device-Name:
WarmTouch® CareDrape™ Cardiae Blanket
Indications for Use:
The WarmTouch Patient Warming System (warming unit and blanket) is intended for prevention and treatment of hypothermia and/or shivering in the critical care environment.
## (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Oella Tell
Division of Cardiovascular & Respiratory Devices
510(k) Number K014121
Prescription Use ✓
OR Over-the-Counter Use _
(Per 21 CFR 801.109)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.